Cargando…
A First‐in‐Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers
RPh201 is a drug extracted from gum mastic that has been studied for its anti‐inflammatory and antibacterial properties. Preclinical studies of RPh201 demonstrated neuroprotective and neuroenhancing effects. Toxicology studies in animals did not reveal safety concerns or genotoxic effects. This sing...
Autores principales: | Hazan, Zadik, Adamsky, Konstantin, Lucassen, Andre, Levin, Leonard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187404/ https://www.ncbi.nlm.nih.gov/pubmed/31250992 http://dx.doi.org/10.1002/cpdd.720 |
Ejemplares similares
-
Delayed (21 Days) Post Stroke Treatment With RPh201, a Botany-Derived Compound, Improves Neurological Functional Recovery in a Rat Model of Embolic Stroke
por: Wang, Chunyang, et al.
Publicado: (2020) -
Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers
por: Chandorkar, Gurudatt, et al.
Publicado: (2017) -
MIJ821 (onfasprodil) in healthy volunteers: First‐in‐human, randomized, placebo‐controlled study (single ascending dose and repeated intravenous dose)
por: Gomez‐Mancilla, Baltazar, et al.
Publicado: (2023) -
Phenotypic characterization of the Hordeum bulbosum derived leaf rust resistance genes Rph22 and Rph26 in barley
por: Yu, Xiaohui, et al.
Publicado: (2022) -
A single ascending dose study of single‐stranded oligodeoxyribonucleotide RO7062931 in Chinese healthy volunteers
por: Cheung, Tsang Tommy, et al.
Publicado: (2023)